Skip to content
Varieties from the European CatalogueGrown in FranceSlow dryingDispatched within 24 working hours — before noonEU delivery — 24-72 hRight of withdrawal — 14 daysCertificate available — per batch
Canna·wikiTHJ-018

Synthetic cannabinoid (SCRA)

Narcotic: generic clause

THJ-018

naphthalen-1-yl-(1-pentylindazol-3-yl)methanone

Aliases.THJ-018 · (naphthalen-1-yl)(1-pentyl-1H-indazol-3-yl)methanone · 1-naphthalenyl(1-pentyl-1H-indazol-3-yl)-methanone

An indazole analogue of JWH-018, a full CB1 and CB2 agonist of nanomolar to subnanomolar affinity.

Updated on

Level of detail

Harm-reduction warning

No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.

Identifiers

Formula
C₂₃H₂₂N₂O
Molar mass
342.40 g·mol⁻¹
CAS
1364933-55-0
PubChem CID
124518671
Origin
A wholly synthetic molecule with no natural occurrence. It is produced outside any pharmaceutical circuit, imported as a powder, then deposited on an inert plant support or incorporated into vaping liquids. The only lawful productions are laboratory analytical standards.
InChIKey
VAKGBPSFDNTMDJ-UHFFFAOYSA-N

In plain terms

THJ-018 is a copy of JWH-018 in which a nitrogen atom has been added at the core of the molecule, which was enough to move it off the lists of banned products without losing its effects. It is a very potent agonist of the cannabis receptors, sold on plant material for smoking, with no human safety data at all.

Receptors and activity

  • CB1
    Agonist
  • CB2
    Agonist
  • Agonist
  • Partial agonist
  • Antagonist
  • Modulator
  • Inverse agonist

Hover over a row for the precise value (Ki, EC50…)

Subjective signature

Hover over an axis to read its definition.

  • Calm
    18
  • Clarity
    10
  • Sleep
    30
  • Appetite
    40
  • High
    75

Editorial estimate, not clinical.

Pharmacology

THJ-018 is a synthetic agonist of cannabinoid receptors of the naphthoylindazole family, a direct analogue of JWH-018 from which it differs only by the replacement of the indole core with an indazole core. That isosteric substitution, without major consequence for activity, sufficed to place it outside the scope of listings by name targeting JWH-018: it illustrates the very mechanism of the race between legislator and clandestine laboratories. Hess and colleagues (2016) class it among the full agonists of CB1 and CB2 receptors, with affinities in the low nanomolar to subnanomolar range, far above that of Δ9-THC. Its metabolism has been characterised on human hepatocytes by Diao and colleagues (2016), who identified thirteen metabolites, hydroxylation of the N-pentyl chain followed by oxidation or glucuronidation constituting the major routes. No human data on dose, tolerance or safety exist.

Origin (pharmaceutical research → illicit market)

No biological route: THJ-018 is a naphthoylindazole obtained by synthesis. The skeleton combines an indazole core bearing a pentyl chain on the nitrogen at position 1, and at position 3 a ketone function linking the naphthalene ring. It is described here by chemical class only.

Structural classification

Class
Synthetic cannabinoid (SCRA)
Origin
A wholly synthetic molecule with no natural occurrence. It is produced outside any pharmaceutical circuit, imported as a powder, then deposited on an inert plant support or incorporated into vaping liquids. The only lawful productions are laboratory analytical standards.
Status
Narcotic: generic clause

References

  1. 1.Hess et coll. 2016 : évaluation pharmacologique des cannabinoïdes de synthèse du « spice »PMID 27429655
  2. 2.Diao et coll. 2016 : métabolisme du THJ-018 et du THJ-2201 sur hépatocytes humainsPMID 26430074

Structured data

InChIKey
VAKGBPSFDNTMDJ-UHFFFAOYSA-N
SMILES
CCCCCN1C2=CC=CC=C2C(=N1)C(=O)C3=CC=CC4=CC=CC=C43
Formula
C23H22N2O
Molar mass
342.40 g·mol⁻¹
CAS
1364933-55-0
PubChem CID
124518671
Machine-readable entry (JSON)

LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.